Feed/Investors/Nippon Venture Capital

Nippon Venture Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-06-30

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$33.8M

across 1 round

LATEST ROUND

Series B · $33.8M · 2026-06-30

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Neusignal Therapeutics A clinical stage neuroscience biotechnology company developing therapeutics	Series B Developing, 2 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts.	$33.8M	2026-06-30	[ PART ]